Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
The review concluded that BPC-157 has the potential to reduce inflammation, promote vascularity, and augment structural, biomechanical, and functional recovery in fracture, muscle, tendon, and ligamentous injury models
Often paired with BPC-157 for synergistic effects in healing and athletic recovery
Because these two categories act through different proposed pathways, one aimed at the growth-hormone axis and the other at localized tissue repair, this pairing (a secretagogue alongside a repair peptide) is the combination most frequently described across bodybuilding peptide discussions, with the secretagogue framed as supporting muscle and recovery capacity and the repair peptide framed as supporting the joints and connective tissue that sustain harder training
Sensory examination was normal, with no deficits, and coordination, gait, and Romberg testing were also unremarkable
Adults over 50, vegetarians, and people taking metformin face higher B12 deficiency risks and should request testing during any anxiety evaluation
US$ 21.10
US$ 29.49
US$ 22.96
US$ 27.53
